Lluis Samaranch (L Samaranch)

Years Active: 2015-2020
Publications (10 Years): 4

The Ohio State University

Universidad de Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Ohio State University May 15 2019

United States

Assistant Profesor :: Neurological Surgery

Education History

Universidad de Navarra

Spain

PHD :: Neuroscience

Universidad de Navarra

Spain

BSC :: School of Science

Universidad de Navarra

Spain

BSC :: School of Science

Publications

Lluis Samaranch, Azucena Pérez-Cañamás, Beatriz Soto-Huelin, Vivek R Sudhakar, Jerónimo Jurado-Arjona, Piotr Hadaczek, Jesús Avila, John R Bringas, Josefina Casas, Haifeng Chen, Xingxuan He, Edward H Schuchman, Seng H Cheng, John Forsayeth, Krystof S Bankiewicz, María Dolores Ledesma
Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A. Science translational medicine 11 (506) (2020)
Alan H Nagahara, Bayard R Wilson, Iryna Ivasyk, Imre Kovacs, Saytam Rawalji, John R Bringas, Phillip J Pivirotto, Waldy San Sebastian, Lluis Samaranch, Krystof S Bankiewicz, Mark H Tuszynski
MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates. Gene therapy 25 (2) (2018)
Lluis Samaranch, B Blits, W San Sebastian, P Hadaczek, J Bringas, V Sudhakar, M Macayan, P J Pivirotto, H Petry, K S Bankiewicz
MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. Gene therapy 24 (4) (2017)
F Green, Lluis Samaranch, H S Zhang, A Manning-Bog, K Meyer, J Forsayeth, K S Bankiewicz
Axonal transport of AAV9 in nonhuman primate brain. Gene therapy 23 (6) (2016)
Lluis Samaranch, P Hadaczek, A P Kells, J R Bringas, D Stockinger, W San Sebastian, M Macayan, S Samineni, P Pivirotto, J Forsayeth, K S Bankiewicz
Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response. Gene therapy 23 (4) (2015)

Lluis Samaranch.css-eqlu8i{font-size:small;padding-left:4px;} (L Samaranch)